StonvexLoading…
StonvexStonvexStonvexCore line items from OCUL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $10.79M | $51.95M | $38.70M | $24.16M |
Operating Income | $-93.34M | $-270.02M | $-200.26M | $-131.56M |
Net Income | $-88.61M | $-265.94M | $-201.28M | $-67.81M |
EPS (Diluted) | $-0.40 | $-1.42 | $-1.15 | $-0.77 |
Total Assets | $732.53M | $808.06M | $410.88M | $451.33M |
Total Liabilities | $150.96M | $153.75M | $152.65M | $145.42M |
Cash & Equivalents | $666.70M | $737.06M | $344.77M | $391.13M |
Free Cash Flow OCF − CapEx | $-70.66M | $-216.89M | $-159.81M | $-103.09M |
Shares Outstanding | 218.90M | 215.93M | 174.95M | 172.93M |